Paracentesis is associated with reduced mortality in patients hospitalized with cirrhosis and ascites

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 3, 2014, Pages

  Orman, Eric S ^a,c   Hayashi, Paul H ^a   Bataller, Ramon ^a,b   Barritt, A Sidney ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b University of North Carolina at Chapel Hill   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Health Services; Liver Fibrosis; NIS Analysis; Peritonitis; Quality of Health Care

Indexed keywords

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; ASCITES; COMORBIDITY; FEMALE; HEPATIC ENCEPHALOPATHY; HOSPITAL CHARGE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MEDICARE; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; PARACENTESIS; SEPSIS; TEACHING HOSPITAL;

HEALTH SERVICES; LIVER FIBROSIS; NIS ANALYSIS; PERITONITIS; QUALITY OF HEALTH CARE;

AGED; ASCITES; FEMALE; GUIDELINE ADHERENCE; HUMANS; LENGTH OF STAY; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PARACENTESIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 84893975712     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.08.025     Document Type: Article

References (23)

1. Gines P., Quintero E., Arroyo V., et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987, 7:122-128.
2. D'Amico G., Garcia-Tsao G., Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. JHepatol 2006, 44:217-231.
3. Tandon P., Garcia-Tsao G. Renal dysfunction is the most important independent predictor of mortality in cirrhotic patients with spontaneous bacterial peritonitis. Clin Gastroenterol Hepatol 2011, 9:260-265.
4. Planas R., Montoliu S., Balleste B., et al. Natural history of patients hospitalized for management of cirrhotic ascites. Clin Gastroenterol Hepatol 2006, 4:1385-1394.
5. Rimola A., Garcia-Tsao G., Navasa M., et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document-International Ascites Club. JHepatol 2000, 32:142-153.
6. De Gottardi A., Thevenot T., Spahr L., et al. Risk of complications after abdominal paracentesis in cirrhotic patients: a prospective study. Clin Gastroenterol Hepatol 2009, 7:906-909.
7. Wong C.L., Holroyd-Leduc J., Thorpe K.E., et al. Does this patient have bacterial peritonitis or portal hypertension? How do I perform a paracentesis and analyze the results?. JAMA 2008, 299:1166-1178.
8. Runyon B.A. Management of adult patients with ascites due to cirrhosis: an update. Hepatology 2009, 49:2087-2107.
9. European Association for the Study of the Liver EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. JHepatol 2010, 53:397-417.
10. Kanwal F., Kramer J., Asch S.M., et al. An explicit quality indicator set for measurement of quality of care in patients with cirrhosis. Clin Gastroenterol Hepatol 2010, 8:709-717.
11. Kanwal F., Kramer J.R., Buchanan P., et al. The quality of care provided to patients with cirrhosis and ascites in the department of veterans affairs. Gastroenterology 2012, 143:70-77.
12. Felisart J., Rimola A., Arroyo V., et al. Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections. Hepatology 1985, 5:457-462.
13. Sort P., Navasa M., Arroyo V., et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. NEngl J Med 1999, 341:403-409.
14. Healthcare Cost and Utilization Project 2009, HCUP Nationwide Inpatient Sample (NIS), Agency for Healthcare Research and Quality, Rockville, MD.
15. Lo Re V., Lim J.K., Goetz M.B., et al. Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study. Pharmacoepidemiol Drug Saf 2011, 20:689-699.
16. Kramer J.R., Davila J.A., Miller E.D., et al. The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases. Aliment Pharmacol Ther 2008, 27:274-282.
17. Quan H., Parsons G.A., Ghali W.A. Validity of procedure codes in International Classification of Diseases, 9th revision, clinical modification administrative data. Med Care 2004, 42:801-809.
18. Elixhauser A., Steiner C., Harris D.R., et al. Comorbidity measures for use with administrative data. Med Care 1998, 36:8-27.
19. Myers R.P., Quan H., Hubbard J.N., et al. Predicting in-hospital mortality in patients with cirrhosis: results differ across risk adjustment methods. Hepatology 2009, 49:568-577.
20. Waikar S.S., Wald R., Chertow G.M., et al. Validity of International Classification of Diseases, Ninth Revision, Clinical Modification codes for acute renal failure. JAm Soc Nephrol 2006, 17:1688-1694.
21. Martin G.S., Mannino D.M., Eaton S., et al. The epidemiology of sepsis in the United States from 1979 through 2000. NEngl J Med 2003, 348:1546-1554.
22. Wickstrom G.C., Kolar M.M., Keyserling T.C., et al. Confidence of graduating internal medicine residents to perform ambulatory procedures. JGen Intern Med 2000, 15:361-365.
23. Chavez-Tapia N.C., Barrientos-Gutierrez T., Tellez-Avila F.I., et al. Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding. Cochrane Database Syst Rev 2010, CD002907.